Literature DB >> 29928162

Contraceptive Use in Women With Inflammatory Bowel Disease.

Lori M Gawron1.   

Abstract

Entities:  

Year:  2018        PMID： 29928162      PMCID： PMC6004041     

Source DB:  PubMed          Journal:  Gastroenterol Hepatol (N Y)        ISSN： 1554-7914


× No keyword cloud information.
  5 in total

Review 1.  Contraceptive use among women with inflammatory bowel disease: A systematic review.

Authors:  Lauren B Zapata; Melissa E Paulen; Catherine Cansino; Polly A Marchbanks; Kathryn M Curtis
Journal:  Contraception       Date:  2010-03-29       Impact factor: 3.375

Review 2.  Reproductive Planning and Contraception for Women with Inflammatory Bowel Diseases.

Authors:  Lori M Gawron; Jessica Sanders; Katelyn P Steele; Ann D Flynn
Journal:  Inflamm Bowel Dis       Date:  2016-02       Impact factor: 5.325

3.  Contraceptive method selection by women with inflammatory bowel diseases: a cross-sectional survey.

Authors:  Lori M Gawron; Andrew J Gawron; Amanda Kasper; Cassing Hammond; Laurie Keefer
Journal:  Contraception       Date:  2014-01-07       Impact factor: 3.375

4.  Fertility and Contraception in Women With Inflammatory Bowel Disease.

Authors:  Jason Martin; Sunanda V Kane; Linda A Feagins
Journal:  Gastroenterol Hepatol (N Y)       Date:  2016-02

5.  The impact of hormonal contraception on disease-related cyclical symptoms in women with inflammatory bowel diseases.

Authors:  Lori M Gawron; Adina Goldberger; Andrew J Gawron; Cassing Hammond; Laurie Keefer
Journal:  Inflamm Bowel Dis       Date:  2014-10       Impact factor: 5.325
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.